Decreased NDRG1 levels in these neoplasms is associated with a poor prognosis [9, 11–13], possibly explained by the ability of NDRG1 to inhibit epithelial-mesenchymal transition (EMT) [14]. Here, NDRG1 is linked to neoplasm.